Immunotherapy (Cancer)

IL-12-Based Immunotherapy Effective In Animal Models

Published in Gene Therapy Weekly, December 9th, 1996

Direct gene transfer of interleukin-12 (IL-12) into tumors results in potent anti-tumoral effects.

IL-12 may be useful against infectious diseases and as an anticancer therapeutic. Several studies have demonstrated that systemic administration of IL-12 could effectively induce tumor regression in several animal models.

C. Asselin-Paturel and colleagues recently presented results of a study examining the antitumor effects of direct gene transfer of IL-12 into tumors at the First Joint Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research, held October 6-10, 1996, in Geneva,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1996-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry